Schroder Investment Management Group Purchases 474,511 Shares of CVS Health Corporation $CVS

Schroder Investment Management Group raised its position in CVS Health Corporation (NYSE:CVS) by 125.8% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 851,625 shares of the pharmacy operator’s stock after purchasing an additional 474,511 shares during the quarter. Schroder Investment Management Group owned 0.07% of CVS Health worth $64,204,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently modified their holdings of the company. Vestmark Advisory Solutions Inc. grew its stake in shares of CVS Health by 48.9% during the 2nd quarter. Vestmark Advisory Solutions Inc. now owns 6,370 shares of the pharmacy operator’s stock worth $439,000 after acquiring an additional 2,091 shares in the last quarter. Prospera Financial Services Inc lifted its position in shares of CVS Health by 7.9% in the second quarter. Prospera Financial Services Inc now owns 23,728 shares of the pharmacy operator’s stock worth $1,638,000 after purchasing an additional 1,728 shares in the last quarter. Connor Clark & Lunn Investment Management Ltd. acquired a new position in CVS Health during the second quarter worth $1,651,000. Pinnacle Wealth Management Advisory Group LLC grew its position in CVS Health by 16.2% in the second quarter. Pinnacle Wealth Management Advisory Group LLC now owns 3,956 shares of the pharmacy operator’s stock valued at $273,000 after purchasing an additional 552 shares in the last quarter. Finally, Zions Bancorporation National Association UT increased its stake in CVS Health by 3.4% in the 2nd quarter. Zions Bancorporation National Association UT now owns 6,467 shares of the pharmacy operator’s stock valued at $446,000 after buying an additional 210 shares during the last quarter. 80.66% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

CVS has been the subject of a number of recent research reports. TD Cowen increased their price objective on shares of CVS Health from $100.00 to $105.00 and gave the stock a “buy” rating in a research note on Wednesday, December 10th. Royal Bank Of Canada reaffirmed an “outperform” rating on shares of CVS Health in a research report on Thursday, December 4th. Morgan Stanley increased their price target on CVS Health from $89.00 to $93.00 and gave the company an “overweight” rating in a research report on Wednesday, December 10th. Truist Financial set a $100.00 price target on CVS Health in a research note on Wednesday, December 10th. Finally, Sanford C. Bernstein reaffirmed a “market perform” rating and set a $91.00 price target on shares of CVS Health in a research report on Tuesday, January 6th. Nineteen equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. Based on data from MarketBeat, CVS Health currently has a consensus rating of “Moderate Buy” and an average price target of $94.91.

CVS Health Stock Down 2.7%

CVS Health stock opened at $76.15 on Wednesday. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.84 and a quick ratio of 0.63. The company’s 50-day moving average is $78.39 and its 200-day moving average is $77.73. The firm has a market capitalization of $96.87 billion, a PE ratio of 55.18, a P/E/G ratio of 0.82 and a beta of 0.49. CVS Health Corporation has a fifty-two week low of $58.35 and a fifty-two week high of $85.15.

CVS Health (NYSE:CVS) last issued its earnings results on Tuesday, February 10th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.00 by $0.09. The business had revenue of $105.69 billion during the quarter, compared to the consensus estimate of $103.67 billion. CVS Health had a net margin of 0.44% and a return on equity of 11.31%. CVS Health’s revenue was up 8.2% on a year-over-year basis. During the same period last year, the business posted $1.19 EPS. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. Sell-side analysts anticipate that CVS Health Corporation will post 5.89 earnings per share for the current year.

CVS Health Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, February 2nd. Stockholders of record on Thursday, January 22nd were paid a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a dividend yield of 3.5%. The ex-dividend date was Thursday, January 22nd. CVS Health’s payout ratio is currently 192.75%.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.